The approval of YESAFILI marks Biocon Biologics’ expansion into the ophthalmology therapeutic area in the United States
_256_384.jpeg)
ASG Group of Eye Hospitals has 165+ branches in 85+ cities across India and abroad
The JV successfully leveraged the strengths of both companies to better serve the fast-growing Indian market
The average time of dilation lasts three to eight hours
JB Chemicals will pay Rs 125 crore to Novartis to license the same drug portfolio for the Indian market
The full transition of Viatris' biosimilars operations to Biocon Biologics in Europe represents another significant milestone
Yesafili, received marketing authorization approval from the European Commission for the European Union
We are redesigning Bayer to focus only on what’s essential for our mission, ‘Health for all, hunger for none’”
RHTC will address a long-standing healthcare access issue for all the local population
Subscribe To Our Newsletter & Stay Updated
